KR20220049619A - 유전자 발현 조절 시스템 - Google Patents

유전자 발현 조절 시스템 Download PDF

Info

Publication number
KR20220049619A
KR20220049619A KR1020227010164A KR20227010164A KR20220049619A KR 20220049619 A KR20220049619 A KR 20220049619A KR 1020227010164 A KR1020227010164 A KR 1020227010164A KR 20227010164 A KR20227010164 A KR 20227010164A KR 20220049619 A KR20220049619 A KR 20220049619A
Authority
KR
South Korea
Prior art keywords
artificial sequence
rna
description
polya
synthetic oligonucleotide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020227010164A
Other languages
English (en)
Korean (ko)
Inventor
라이싱 옌
리밍 뤄
조셀린 뒌-야 제아
조셀린 Љ-야 제아
Original Assignee
베이롤 칼리지 오브 메드신
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 베이롤 칼리지 오브 메드신 filed Critical 베이롤 칼리지 오브 메드신
Publication of KR20220049619A publication Critical patent/KR20220049619A/ko
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/115—Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith ; Nucleic acids binding to non-nucleic acids, e.g. aptamers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/16—Aptamers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/50—Vector systems having a special element relevant for transcription regulating RNA stability, not being an intron, e.g. poly A signal

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
KR1020227010164A 2019-08-30 2020-08-28 유전자 발현 조절 시스템 Pending KR20220049619A (ko)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201962894611P 2019-08-30 2019-08-30
US62/894,611 2019-08-30
US201962904635P 2019-09-23 2019-09-23
US62/904,635 2019-09-23
US202063043504P 2020-06-24 2020-06-24
US63/043,504 2020-06-24
PCT/US2020/048561 WO2021041924A2 (en) 2019-08-30 2020-08-28 System for regulating gene expression

Publications (1)

Publication Number Publication Date
KR20220049619A true KR20220049619A (ko) 2022-04-21

Family

ID=74683442

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020227010164A Pending KR20220049619A (ko) 2019-08-30 2020-08-28 유전자 발현 조절 시스템

Country Status (11)

Country Link
US (1) US20220290147A1 (cg-RX-API-DMAC10.html)
EP (1) EP4022065A4 (cg-RX-API-DMAC10.html)
JP (2) JP7737152B2 (cg-RX-API-DMAC10.html)
KR (1) KR20220049619A (cg-RX-API-DMAC10.html)
CN (1) CN115279902A (cg-RX-API-DMAC10.html)
AU (1) AU2020335909A1 (cg-RX-API-DMAC10.html)
BR (1) BR112022003512A2 (cg-RX-API-DMAC10.html)
CA (1) CA3152513A1 (cg-RX-API-DMAC10.html)
IL (1) IL290944A (cg-RX-API-DMAC10.html)
MX (1) MX2022002390A (cg-RX-API-DMAC10.html)
WO (1) WO2021041924A2 (cg-RX-API-DMAC10.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2769991C2 (ru) 2015-11-12 2022-04-12 Байлор Колледж Оф Медсин Экзогенный контроль экспрессии генов млекопитающих с помощью опосредованной аптамерами модуляции полиаденилирования
US20260053851A1 (en) 2021-08-11 2026-02-26 Sana Biotechnology, Inc. Inducible systems for altering gene expression in hypoimmunogenic cells

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2305813A3 (en) * 2002-11-14 2012-03-28 Dharmacon, Inc. Fuctional and hyperfunctional sirna
EP1733034A4 (en) 2004-03-15 2010-01-20 Biogen Idec Inc METHOD AND CONSTRUCTS FOR THE EXPRESSION OF POLYPEPTIDE MULTIMERS IN EUKARYONTIC CELLS USING ALTERNATIVE SPLEISSEN
US20050282190A1 (en) * 2004-04-09 2005-12-22 Hua Shi Modular design and construction of nucleic acid molecules, aptamer-derived nucleic acid constructs, RNA scaffolds, their expression, and methods of use
CA2566286A1 (en) * 2004-05-11 2005-12-08 Rnai Co., Ltd. Polynucleotide causing rna interfere and method of regulating gene expression with the use of the same
US7825229B2 (en) * 2005-03-25 2010-11-02 Rosetta Genomics Ltd. Lung cancer-related nucleic acids
US8178503B2 (en) * 2006-03-03 2012-05-15 International Business Machines Corporation Ribonucleic acid interference molecules and binding sites derived by analyzing intergenic and intronic regions of genomes
US20150284738A1 (en) * 2006-12-29 2015-10-08 Rodina Holding S.A. Artificial dna sequence with optimized leader function in 5' (5'-utr) for the improved expression of heterologous proteins in plants
US20130157279A1 (en) * 2010-09-01 2013-06-20 Nec Corporation Method for detecting target substance and aptamer set, sensor, and apparatus used in the method
US20130239236A1 (en) * 2010-10-01 2013-09-12 R1 B3 Holdings B.V. Regulation of translation of expressed genes
EP2812436A4 (en) * 2012-02-10 2016-05-11 Univ Leland Stanford Junior MINI-INTRONIC PLASMID VECTORS
WO2013173637A1 (en) * 2012-05-16 2013-11-21 Rana Therapeutics, Inc. Compositions and methods for modulating gene expression
US9567581B2 (en) * 2012-08-07 2017-02-14 The General Hospital Corporation Selective reactivation of genes on the inactive X chromosome
WO2016126747A1 (en) 2015-02-02 2016-08-11 Meiragtx Uk Limited Regulation of gene expression by aptamer-mediated modulation of alternative splicing
CA2979229A1 (en) * 2015-03-11 2016-09-15 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Rp2 vectors for treating x-linked retinitis pigmentosa
RU2769991C2 (ru) * 2015-11-12 2022-04-12 Байлор Колледж Оф Медсин Экзогенный контроль экспрессии генов млекопитающих с помощью опосредованной аптамерами модуляции полиаденилирования

Also Published As

Publication number Publication date
JP7737152B2 (ja) 2025-09-10
EP4022065A4 (en) 2024-02-14
WO2021041924A2 (en) 2021-03-04
CA3152513A1 (en) 2021-03-04
CN115279902A (zh) 2022-11-01
JP2025118711A (ja) 2025-08-13
EP4022065A2 (en) 2022-07-06
US20220290147A1 (en) 2022-09-15
BR112022003512A2 (pt) 2022-05-17
JP2022546408A (ja) 2022-11-04
MX2022002390A (es) 2022-05-13
IL290944A (en) 2022-04-01
WO2021041924A3 (en) 2021-04-08
AU2020335909A1 (en) 2022-04-14

Similar Documents

Publication Publication Date Title
AU2023201630B2 (en) Circular RNA for translation in eukaryotic cells
JP2024536853A (ja) 環状rnaおよびその調製方法
KR20230076820A (ko) 진핵생물 유전체 공학을 위한 합성 미니어처 crispr-cas(casmini) 시스템
KR20210135265A (ko) 원형 폴리리보뉴클레오티드 및 그의 약제학적 조성물
KR20230002401A (ko) C9orf72의 표적화를 위한 조성물 및 방법
CN112513250A (zh) 用于跟踪和操纵细胞rna的融合蛋白和融合核糖核酸
CN114174520A (zh) 用于选择性基因调节的组合物和方法
CN107522787A (zh) 在细胞内产生点突变的融合蛋白、其制备及用途
CN105960413A (zh) 人工dna-结合蛋白及其用途
JP6956416B2 (ja) トランスポゾン系、それを含むキット及びそれらの使用
KR102876612B1 (ko) 하나 이상의 비-고유 꼬리 섬유를 가지는 비-복제성 형질도입 입자 및 형질도입 입자-기반 리포터 시스템
CN117015605A (zh) 使用工程化rna通过利用内源性adar进行靶向rna编辑
KR20230129162A (ko) 제1형 근긴장성 이영양증을 치료하기 위한 rna 표적화조성물 및 방법
JP7667595B2 (ja) Aqp1 RNAを標的とするsgRNA及びそのベクターと使用
CN116783295A (zh) 指导rna的新型设计及其用途
CN118291452B (zh) 一种基于i型内含子核酶体外制备环状rna的系统及其应用
KR20250153190A (ko) 환형 리보핵산을 합성하기 위한 조성물 및 방법
JP2025118711A (ja) 遺伝子発現を調節するためのシステム
WO2024238321A1 (en) Compositions and methods for targeted epigenetic modification
WO2024040202A1 (en) Fusion proteins and uses thereof for precision editing
CN101313067B (zh) 以rna干扰特异性抑制基因表达的dna构建体
JPWO2018139637A1 (ja) 核酸封入aav中空粒子
JP2025514304A (ja) 遺伝子治療法のための組織特異的遺伝子外セーフハーバーの同定
CN118480526A (zh) 一种转座酶、转座子、转座子系统及其应用
CN118652889B (zh) 一种环状核酶系统及其应用

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

D13-X000 Search requested

St.27 status event code: A-1-2-D10-D13-srh-X000

D21 Rejection of application intended

Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D21-EXM-PE0902 (AS PROVIDED BY THE NATIONAL OFFICE)

PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11 Administrative time limit extension requested

Free format text: ST27 STATUS EVENT CODE: U-3-3-T10-T11-OTH-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11 Administrative time limit extension requested

Free format text: ST27 STATUS EVENT CODE: U-3-3-T10-T11-OTH-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11 Administrative time limit extension requested

Free format text: ST27 STATUS EVENT CODE: U-3-3-T10-T11-OTH-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

E13 Pre-grant limitation requested

Free format text: ST27 STATUS EVENT CODE: A-2-3-E10-E13-LIM-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-NAP-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000